Last Updated: 17/12/2024
Analysis of programmatic Mass Drug Administration for malaria in Zambia
Objectives
To assess the short-term impact of programatic Mass Drug Administration (pMDA) on the incidence of confirmed malaria cases, using routine data collected at health facilities and by community health workers in a low transmission province in Zambia.
Tulane University, United States
National Malaria Elimination Centre (NMEC) Zambia
In 2016, the Zambian National Malaria Elimination Centre started pMDA campaigns with dihydroartemisinin-piperaquine as a malaria elimination tool in Southern Province. Two rounds were administered, 2 months apart (coverage 70% and 57%, respectively). We evaluated the impact of 1 year of pMDA on malaria incidence using routine data.
Programmatic MDA was conducted in health facility catchment areas (HFCAs) with greater than 50 cases/1000 people per year. Ten HFCAs with incidence rates marginally above this threshold (pMDA group) were compared with 20 HFCAs marginally below (comparison group).
Drug-based Strategies
Health Systems
Impact of Interventions
Operational Research
Residual Transmission
Nov 2016 — Nov 2017
Related Resources
